Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection Ira M. LevitonMaria Amodio-Groton Current Opinion Open access 22 February 2022 Pages: 193 - 197
Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy Women Milko RadicioniChiara LeurattiBarbara Cometti Original Research Article Open access 09 February 2022 Pages: 199 - 206
Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients Yan RongPenny ColbourneTony K. L. Kiang Original Research Article 18 February 2022 Pages: 207 - 219
The Effect of Hepatic Impairment on the Pharmacokinetics of Dacomitinib Joseph PiscitelliJoseph ChenWeiwei Tan Original Research Article Open access 23 February 2022 Pages: 221 - 235
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis Andrea MarcellusiGianluca FabianoFrancesco Saverio Mennini Original Research Article Open access 26 February 2022 Pages: 237 - 242
The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study Anton L. V. AvanceñaJames G. KahnElliot Marseille Original Research Article Open access 01 March 2022 Pages: 243 - 252
Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial Yuki TakumotoTakeru ShiroiwaMasataka Sawaki Original Research Article Open access 01 March 2022 Pages: 253 - 262
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) Stewart J. TepperJessica AilaniAntje Tockhorn-Heidenreich Original Research Article Open access 18 January 2022 Pages: 263 - 275
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER) Stewart J. TepperJessica AilaniAntje Tockhorn-Heidenreich Correction Open access 07 March 2022 Pages: 277 - 277
Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis Carlos EscobarVivencio BarriosCarolina Requeijo Correction 14 February 2022 Pages: 279 - 280
Correction to: Adverse Events with d-penicillamine Therapy in Hepatic Wilson’s Disease: A Single-Center Retrospective Audit Sanjay KumarBiswa Ranjan PatraAkash Shukla Correction 23 February 2022 Pages: 281 - 282
Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma Baek‑Yeol RyooDaniel H. PalmerHo Yeong Lim Correction 27 February 2022 Pages: 283 - 283